drugset / Trial / NCT00248053

Use of Curcumin in the Lower Gastrointestinal Tract in Familial Adenomatous Polyposis Patients

NCT00248053

Phase 2 Withdrawn Johns Hopkins University
Non-randomizedCrossoverOpen-label

Summary

The purpose of this study is to assess if curcumin, a commonly used food spice, can regress colorectal adenomatous polyps in patients with familial adenomatous polyposis, an inherited form of colorectal cancer.

Timeline

Start
2005-11
Primary completion
2008-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Curcumin Small molecule 500 mg Oral